Evidence map›Paper›PMID 40433659›Full record

ArticleFrontiers in cellular and infection microbiology2025

Involvement of the

Peishan Li, Leping Yan, Jingjie Song, Chengfeng Lin, Fangyin Zeng, Shihan Zeng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Extended-Spectrum β-Lactamase-ProducingInfection and drug resistance · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Peishan Li *Department of Clinical Laboratory, Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.
Leping Yan *Department of Clinical Laboratory, Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.
Jingjie SongDepartment of Clinical Laboratory, Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.
Chengfeng LinDepartment of Clinical Laboratory, Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.
Fangyin ZengDepartment of Clinical Laboratory, Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.
Shihan ZengDepartment of Clinical Laboratory, Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aimed to investigate the mechanism underlying a peculiar resistance phenotype in Methods: Antimicrobial susceptibility testing, plasmid conjugation experiments, whole-genome sequencing, and bioinformatic analyses were employed to characterize the resistance phenotype and identify genetic determinants. Results: A total of 20 Discussion: The primary driver of this phenotype in

Indexed as

Anti-Bacterial Agentsbeta-LactamasesKlebsiella pneumoniaeCefepimeCeftazidimeComputational BiologyConjugation, GeneticHumansKlebsiella InfectionsMicrobial Sensitivity TestsPhenotypePlasmidsWhole Genome SequencingAnti-Bacterial Agentsbeta-Lactamasesbeta-lactamase TEM-3CefepimeCeftazidimecefepimeceftazidimeCTX-M-3Klebsiella pneumoniaepeculiar resistance phenotype

Identifiers

PMID40433659
PMCPMC12106457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.